About this trial

This prospective study investigates the effects of neoadjuvant therapy on endothelial function, microvascular tissue density, and tissue fibrosis in patients with colorectal cancer and their association with perioperative complications. The primary objective is to assess differences in microvascular tissue density between patients who received neoadjuvant therapy and those who did not, biomarkers, and demographic factors between patients who received neoadjuvant therapy and those who underwent surgery as initial treatment, and to compare clinical outcomes. The study will include 34 patients treated with neoadjuvant therapy and 34 patients for whom surgery is the first-line treatment. Patients will be followed until discharge from the hospital, and complications after discharge will be monitored through medical records one month after surgery.

Eligibility criteria

Qualifiers

Adults aged ≥18 years with histologically confirmed colorectal cancer

Planned surgical treatment for colorectal cancer (either laparoscopic LPSC or open laparotomy)

Ability to understand the study protocol and provide written informed consent.

Both sexes

Disqualifiers

Age <18 years

Patients who are not conscious, not oriented, or unable to provide informed consent

Patients unable to understand the study protocol

Emergency surgical cases

Trial design

Treatments tested in this trial

  • Skin and subcutaneous tissue sampling for histopathological analysis
  • Blood sampling for laboratory analyses before and after surgery

Treatment groups

68 Participants
are divided into 2 treatment groups

Locations

1
KBC Osijek31000, Osijek Croatia

Sponsors and collaborators

Osijek University Hospital

Lead sponsor